All times are listed in CEST (Central European Summer Time)
Browsing Over 461 Presentations
Sort By
José Baselga: Cancer’s fiercest opponent (ID 49)
Panel discussion (ID 477)
Lecture Time
11:05 - 11:20
Authors
Session Name
Room
Berlin Hall
Date
Tue, 03.05.2022
Time
10:00 - 11:20
José Baselga: Cancer’s fiercest opponent (ID 49)
Introduction of the documentary (ID 475)
Lecture Time
10:04 - 10:08
Session Name
Room
Berlin Hall
Date
Tue, 03.05.2022
Time
10:00 - 11:20
José Baselga: Cancer’s fiercest opponent (ID 49)
Documentary (ID 476)
Lecture Time
10:08 - 11:05
Speakers
Authors
Session Name
Room
Berlin Hall
Date
Tue, 03.05.2022
Time
10:00 - 11:20
José Baselga: Cancer’s fiercest opponent (ID 49)
Welcome address from ESMO (ID 474)
Lecture Time
10:00 - 10:04
Session Name
Room
Berlin Hall
Date
Tue, 03.05.2022
Time
10:00 - 11:20
AstraZeneca - Controversies in Breast Cancer (ID 48)
Treatment beyond CDK4/6i - what comes next? (ID 471)
Lecture Time
12:00 - 12:15
Session Name
Room
Cologne Hall
Date
Tue, 03.05.2022
Time
11:30 - 12:30
Gilead - Triple-Negative Breast Cancer: See Beyond the Negatives (ID 35)
Live Q&A (ID 411)
Lecture Time
11:30 - 11:30
Room
Munich Hall
Date
Tue, 03.05.2022
Time
11:30 - 12:30
YO “HowTo” Session: How to move genomic profiling to clinical practice by multidisciplinary collaboration? (ID 3)
Clinical case presentation from the molecular tumor board (ID 18)
Lecture Time
11:30 - 11:30
Speakers
Session Name
Room
Frankfurt Hall
Date
Tue, 03.05.2022
Time
11:30 - 12:30
PER-sponsored supported by Sanofi Genzyme - Tumor Board: How the Experts Approach Personalized Care Plans in ER+ BC (ID 5)
Tumor Board 1: Current Management Options for HR+/HER2- Metastatic Breast Cancer (ID 268)
Lecture Time
11:30 - 11:30
Speakers
Room
Hamburg Hall
Date
Tue, 03.05.2022
Time
11:30 - 12:30
AstraZeneca - Controversies in Breast Cancer (ID 48)
Jumping the Gun - Should we wait for OS data in eBC? (ID 469)
Lecture Time
11:30 - 11:45
Session Name
Room
Cologne Hall
Date
Tue, 03.05.2022
Time
11:30 - 12:30
Gilead - Triple-Negative Breast Cancer: See Beyond the Negatives (ID 35)
Evolving treatment landscape in TNBC (ID 409)
Lecture Time
11:30 - 11:30
Speakers
Authors
Room
Munich Hall
Date
Tue, 03.05.2022
Time
11:30 - 12:30
PER-sponsored supported by Sanofi Genzyme - Tumor Board: How the Experts Approach Personalized Care Plans in ER+ BC (ID 5)
Post-session Questions (ID 271)
Lecture Time
12:00 - 12:00
Speakers
Room
Hamburg Hall
Date
Tue, 03.05.2022
Time
11:30 - 12:30
AstraZeneca - Controversies in Breast Cancer (ID 48)
Q&A / discussion (ID 478)
Lecture Time
12:15 - 12:30
Speakers
Authors
Session Name
Room
Cologne Hall
Date
Tue, 03.05.2022
Time
11:30 - 12:30